Senseonics Holdings, Inc. Common Stock's (SENS) Hold Rating Reaffirmed at Stifel Nicolaus

Key Points

• Stifel Nicolaus reaffirmed its Hold rating on SENS while raising its price target from $9 to $10; that target implies 22% downside from the prior close.
• Senseonics reported third-quarter revenue of about $19.6 million, up roughly 140% year over year, and raised its FY 2026 revenue guidance to $68 million–$70 million.
• The company’s quarterly loss was $0.50 per share, slightly worse than analysts’ $0.49 estimate. Analyst views overall remain mixed, with MarketBeat reporting an average Hold rating.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report)'s stock had its "hold" rating reissued by stock analysts at Stifel Nicolaus in a note issued to investors on Tuesday, Benzinga reports. They currently have a $10.00 price objective on the stock, up from their prior price objective of $9.00. Stifel Nicolaus's target price points to a potential downside of 22.02% from the stock's previous close.

SENS has been the topic of a number of other reports. Wall Street Zen raised shares of Senseonics Holdings, Inc. Common Stock from a "strong sell" rating to a "sell" rating in a report on Saturday, August 8th. Weiss Ratings raised shares of Senseonics Holdings, Inc. Common Stock from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Wednesday, November 4th. Mizuho reduced their target price on shares of Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an "outperform" rating on the stock in a report on Wednesday, July 15th. Raymond James Financial upgraded Senseonics Holdings, Inc. Common Stock from an "underperform" rating to a "market perform" rating in a research note on Tuesday. Finally, Barclays initiated coverage on shares of Senseonics Holdings, Inc. Common Stock in a research report on Wednesday, October 7th. They set an "equal weight" rating and a $10.00 target price on the stock. Three analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $13.60.

Senseonics Holdings, Inc. Common Stock Price Performance

SENS opened at $12.82 on Tuesday. The stock has a market capitalization of $536.00 million, a P/E ratio of -5.79 and a beta of 1.04. Senseonics Holdings, Inc. Common Stock has a 52-week low of $4.79 and a 52-week high of $13.88. The company has a debt-to-equity ratio of 0.62, a quick ratio of 6.40 and a current ratio of 6.74. The company's 50-day simple moving average is $9.12 and its two-hundred day simple moving average is $7.26.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) last released its earnings results on Monday, November 9th. The company reported ($0.50) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.49) by ($0.01). Senseonics Holdings, Inc. Common Stock had a negative return on equity of 165.80% and a negative net margin of 225.09%. The firm had revenue of $19.56 million during the quarter. As a group, analysts predict that Senseonics Holdings, Inc. Common Stock will post -2.31 EPS for the current year.

Insiders Place Their Bets

In other Senseonics Holdings, Inc. Common Stock news, Director Douglas Roeder acquired 13,953 shares of the firm's stock in a transaction on Wednesday, August 19th. The stock was purchased at an average price of $8.98 per share, with a total value of $125,297.94. Following the completion of the acquisition, the director directly owned 171,191 shares in the company, valued at $1,537,295.18. This trade represents a 8.87% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 4.70% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Senseonics Holdings, Inc. Common Stock

Several large investors have recently made changes to their positions in the business. BlackRock Inc. acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock in the second quarter worth $15,867,000. Masters Capital Management LLC increased its holdings in shares of Senseonics Holdings, Inc. Common Stock by 100.0% during the 1st quarter. Masters Capital Management LLC now owns 500,000 shares of the company's stock worth $3,330,000 after purchasing an additional 250,002 shares during the period. Bank of America Corp DE bought a new position in shares of Senseonics Holdings, Inc. Common Stock during the 2nd quarter worth about $2,241,000. Readystate Asset Management LP bought a new stake in shares of Senseonics Holdings, Inc. Common Stock in the 2nd quarter worth about $574,000. Finally, Penn Capital Management Company LLC bought a new stake in Senseonics Holdings, Inc. Common Stock during the 2nd quarter worth about $535,000. Institutional investors own 12.36% of the company's stock.

Key Headlines Impacting Senseonics Holdings, Inc. Common Stock

Here are the key news stories impacting Senseonics Holdings, Inc. Common Stock this week:

• Positive Sentiment: Senseonics raised its FY 2026 revenue guidance to $68 million–$70 million, up from $62 million–$66 million and above the $64.2 million consensus estimate. It also lifted its full-year gross-margin outlook to more than 60%. Third-quarter 2026 results
• Positive Sentiment: Third-quarter revenue was about $19.6 million, up approximately 140% year over year, and exceeded analyst revenue estimates, highlighting strong sales growth. Q3 results and revenue estimates
• Positive Sentiment: HC Wainwright reaffirmed its Buy rating and set a $14 price target. Raymond James also upgraded SENS, moving its rating from Underperform to Market Perform. HC Wainwright rating
• Negative Sentiment: The company reported a third-quarter loss of $0.50 per share, slightly worse than the $0.49 consensus loss and wider than the $0.43 loss a year earlier. Quarterly earnings results

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc is a medical technology company focused on developing and commercializing long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its CGM technology is designed to measure glucose levels continuously through a small sensor inserted under the skin, with readings transmitted to an external smart transmitter and mobile application.

The company's primary product is the Eversense CGM system. Unlike many conventional CGM systems that use an externally worn sensor, Eversense uses an implantable sensor and a removable, rechargeable transmitter worn over the sensor site.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.